Get the Daily Brief
Latest Biotech News
Parkinson’s Disease Hypoxia Therapy: Mouse Models Show Symptom Reversal
Groundbreaking research from the Broad Institute and Massachusetts General Brigham reveals that exposure to low-oxygen environments ameliorates neurodegeneration and motor dysfunction in mouse...
Cancer Immunotherapy Advances: Bacterial Consortium and Immune Checkpoint Insights
Researchers have developed an immune-independent bacterial therapy demonstrating complete tumor remission in both immunocompetent and immunocompromised mice, representing a revolutionary advance...
AI in Medical Diagnostics: Chatbot Risks and Genomic Variant Benchmarking
Cutting-edge studies expose vulnerabilities in AI chatbots' medical information accuracy, underscoring the urgency for improved safeguards in healthcare applications. Complementing this, novel...
Gene Editing and RNA Therapy: Chromosome Engineering and Dual-Gene Cancer Silencing
Chinese scientists achieve megabase-scale programmable chromosome engineering, enabling large-scale, precise DNA modifications without traces, marking a milestone in genome editing. Alongside,...
Biopharma Market Movements: Pharma Tariff Threats and Company Pipeline Updates
Pharmaceutical giants face potential U.S. tariffs up to 250%, prompting strategic adjustments across the industry. Pfizer's CEO confirms readiness to collaborate on direct-to-consumer drug sales...
Microplastics Research Breakthroughs: Human Blood Detection and Environmental Impacts
Advanced analytical techniques have quantified micro- and nanoplastics circulating in human blood, raising concerns about pervasive environmental exposure. Concurrent environmental studies explore...
Neonatal and Pediatric Advances: Diagnosis, Immunity, and Disease Management
Emerging research in neonatal and pediatric care highlights innovative diagnostic and therapeutic approaches from molecular to clinical levels. Key studies include precision neonatology improving...
Oncology Therapeutics: Cellular and Molecular Innovation in Cancer Treatment
Cancer research unveils novel molecular targets and therapeutic strategies, including CAR macrophages engineered via mRNA extracellular vesicles reducing lung metastasis, new antibody-drug...
Biotech Industry Financials and Collaborations: Q2 Earnings and Strategic Partnerships
Recent financial disclosures highlight varied biotech performance: Adaptive Biotechnologies reports a 36% Q2 revenue increase driven by minimal residual disease testing, Sophia Genetics grows...
Neurodegenerative Disease Biomarkers and Mechanisms: Alzheimer’s and Parkinson’s Insights
Research deepens understanding of neurodegenerative disorders through identification of novel biomarkers and molecular mechanisms. Notably, Merck reveals preclinical promise of MK-2214 targeting...
Low-Oxygen Therapy Reverses Parkinson’s Symptoms in Mice
Groundbreaking studies from the Broad Institute and Massachusetts General Hospital reveal that hypoxia, or exposure to low oxygen levels, can restore neuronal function and alleviate motor symptoms...
Bio-Techne’s Q4 Revenue Growth and Exosome Diagnostics Sale to MDxHealth
Bio-Techne reported a 4% year-over-year revenue increase in fiscal fourth quarter 2025, driven by growth in cell therapy and protein analysis instruments amid a resilient pharma market. The...
Adaptive Biotechnologies’ MRD Testing Drives Q2 Revenue Surge
Adaptive Biotechnologies posted an impressive 36% year-over-year revenue increase in Q2 2025, largely fueled by strong demand for its minimal residual disease (MRD) testing business. The MRD...
Quantum-Si Faces NIH Funding Challenges as Q2 Revenues Dip
Quantum-Si reported a 5% decline in Q2 2025 revenues primarily due to reduced NIH funding impacting capital sales. The proteomics company missed Wall Street revenue expectations but continued...
QuidelOrtho Adjusts Respiratory Diagnostics Guidance Amid Covid Trends
QuidelOrtho revised its respiratory diagnostic sales forecast downward due to the absence of an anticipated summer Covid surge, although it reaffirmed full-year revenue guidance. CFO Joe Busky...
Evolutionary Insights into Yersinia pestis Genomic Rearrangements
Researchers from the Chinese Academy of Sciences and military medical institutions have analyzed 242 Yersinia pestis genomes to unravel the pathogen’s evolutionary dynamics shaped by extensive...
Milestone in Megabase-Scale Precision Genome Editing
A Chinese research team led by Prof. Gao Caixia has developed Programmable Chromosome Engineering (PCE) systems enabling precise genetic manipulations at the megabase scale in higher organisms,...
Replimmune Scientists Protest FDA Rejection of Melanoma Drug RP1
In an extraordinary move, 22 expert researchers behind the Phase III IGNYTE trial for Replimmune’s melanoma candidate RP1 publicly challenged the FDA’s complete response letter that led to the...
Sophia Genetics Expands AstraZeneca Partnership Amid 16% Q2 Sales Growth
Sophia Genetics reported a 16% year-over-year increase in Q2 2025 revenues, boosted by solid growth outside of a transient biopharma sector slowdown. The Swiss bioinformatics firm expanded its...
Pfizer CEO Comments on Pharma Direct-to-Consumer Sales and U.S.-China Competition
Pfizer CEO Albert Bourla emphasized the need for government support to boost U.S. biotech competitiveness relative to China and expressed readiness among drugmakers to collaborate with the Trump...